PUBLICATIES NEFROLOGIE 2013 Pagina
|
|
- Martin Stephens
- 8 years ago
- Views:
Transcription
1 PUBLICATIES NEFROLOGIE 2013 Pagina Abbasi A, Corpeleijn E, Gansevoort RT, Gans ROB, Hillege HL, Stolk RP, Navis GJ, Bakker SJL, Dullaart RPF. Role of HDL cholesterol and estimates of HDL particle composition in future development of type 2 diabetes in the general population: The PREVEND Study. J Clin Endocrinol Metab. 2013;98:E Abdelmalek JA, Gansevoort RT, Lambers Heerspink HJ, Ix JH, Rifkin DE. Estimated albumin excretion rate versus urine albumin-creatinine ratio for the assessment of albuminuria: A diagnostic test study from the Prevention of Renal and Vascular Endstage Disease (PREVEND) Study. Am J Kidney Dis. 2013;S (13) Abdulahad WH, Lepse N, Stegeman CA, Huitema MG, Doornbos-Meer van der B, Tadema HH, Rutgers A, Limburg PC, Kallenberg CGM, Heeringa P. Increased frequency of circulating IL-21 producing Th-cells in patients with granulomatosis with polyangiitis. Arthritis Res Ther. 2013; 24;15:R70 4. Altorf-van der Kuil W, Brink EJ, Boetje M, Siebelink E, Bijlsma S, Engberink MF, Veer PV, Tomé D, Bakker SJL, Baak MA van, Geleijnse JM. Identification of biomarkers for intake of protein from meat, dairy products and grains: a controlled dietary intervention study. Br J Nutr. 2013;110: Andrésdóttir G, Bakker SJL, Hansen HP, Parving HH, Rossing P. Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetes. Diabet Med. 2013; Assa S, Hummel YM, Voors AA, Kuipers J, Westerhuis R, Groen H, Bakker SJL, Muller Kobold AC, Oeveren W van, Struck J, Jong PE de, Franssen CFM. Hemodialysis-induced regional left ventricular systolic dysfunction and inflammation: A cross-sectional study. Am J Kidney Dis. 2013; S : Assa S, Hummel YM, Voors AA, Kuipers J, Groen H, Jong PE de, Westerhuis R, Franssen CFM. Changes in left ventricular diastolic function during hemodialysis sessions. Am J Kidney Dis. 2013;62: Assa S, Gansevoort RT, Westerhuis R, Kobold AC, Voors AA, Jong PE de, Bakker SJL, Franssen CFM. Determinants and prognostic significance of an intra-dialysis rise of cardiac troponin I measured by sensitive assay in hemodialysis patients. Clin Res Cardiol. 2013;102: Baia LC, Humalda JK, Vervloet MG, Navis GJ, Bakker SJL, Borst MH de; NIGRAM Consortium. Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation. Clin J Am Soc Nephrol. 2013;8: Bakker SJL. Chronic kidney disease: Defining clinical cut-offs for albumin:creatinine ratio. Nat Rev Nephrol. 2013;9: Berg E van den, Engberink MF, Brink EJ, Baak MA van, Gans ROB, Navis GJ, Bakker SJL. Dietary protein, blood pressure and renal function in renal transplant recipients. Br J Nutr. 2013;109: Berndt SI, Gustafsson S, Mägi R, Ganna A, Wheeler E, Feitosa MF et al including Navis GJ. Genomewide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet. 2013;45: Boertien WE, Meijer E, Li J, Bost JE, Struck J, Flessner MF, Gansevoort RT, Torres VE; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease CRISP. Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohort. Am J Kidney Dis. 2013;61: Boertien WE, Riphagen IJ, Drion I, Alkhalaf A, Bakker SJL, Groenier KH, Struck J, Jong PE de, Bilo HJ, Kleefstra N, Gansevoort RT. Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33). Diabetologia. 2013;56:
2 PUBLICATIES NEFROLOGIE 2013 Pagina Boertien WE, Meijer E, Jong PE de, Bakker SJL, Czerwiec FS, Struck J, Oberdhan D, Shoaf SE, Krasa HB, Gansevoort RT. Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease. Kidney Int. 2013;84: Brouwers FP, Boer RA de, Harst P van der, Voors AA, Gansevoort RT, Bakker SJL, Hillege HL, Veldhuisen DJ van, Gilst WH van. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J. 2013;34: CLOTS (Clots in Legs Or stockings after Stroke) Trials Collaboration, Dennis M, Sandercock P, Reid J, Graham C, Forbes J, Murray G including Navis GJ. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial. Lancet. 2013;382: Damman J, Seelen MAJ. Mannan binding lectin: a two-faced regulator of renal allograft injury? Kidney Int. 2013;83: Deetman PE, Bakker SJL, Dullaart RPF. High sensitive C-reactive protein and serum amyloid A are inversely related to serum bilirubin: effect-modification by metabolic syndrome. Cardiovasc Diabetol. 2013;12: Dijk S van, Beukel TO van den, Kaptein AA, Honig A, le Cessie S, Siegert CE, Boeschoten EW, Krediet RT, Dekker FW; NECOSAD Study Group including collaborators Stegeman CA et al. How baseline, new-onset, and persistent depressive symptoms are associated with cardiovascular and noncardiovascular mortality in incident patients on chronic dialysis. J Psychosom Res. 2013;74: Eersel ME van, Joosten JMH, Gansevoort RT, Dullaart RPF, Slaets JP, Izaks GJ. The interaction of age and type 2 diabetes on executive function and memory in persons aged 35 years or older. PLoS One. 2013;8:e Emans ME, Gaillard CAJM, Pfister R, Tanck MW, Boekholdt SM, Wareham NJ, Khaw KT. Red cell distribution width is associated with physical inactivity and heart failure, independent of established risk factors, inflammation or iron metabolism; the EPIC-Norfolk study. Int J Cardiol. 2013; 9;168: Emans ME, Gaillard CAJM, Pfister R, Tanck MW, Boekholdt SM, Wareham NJ, Khaw KT. Response to letter by Balta et al. Int J Cardiol. 2013;169: Engel MF, Postma DF, Hulscher ME, Teding van Berkhout F, Emmelot-Vonk MH, Sankatsing S, Gaillard CAJM, Bruns AH, Hoepelman AI, Oosterheert JJ. Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP. Eur Respir J. 2013;41: Franssen CFM, Navis GJ. Chronic kidney disease: RAAS blockade and diastolic heart failure in chronic kidney disease. Nat Rev Nephrol. 2013;9: Gaillard CAJM, Schiffelers RM. Red blood cell: barometer of cardiovascular health? Cardiovasc Res 2013;98: Ganesh SK, Tragante V, Guo W, Guo Y, Lanktree MB, Smith EN, Johnson T, Castillo BA,EN et al including Gansevoort RT; CARDIOGRAM, METASTROKE, LifeLines Cohort Study. Loci influencing blood pressure identified using a cardiovascular gene-centric array. Hum Mol Genet. 2013;22: Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, Matsushita K, Wen CP. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382: Grootendorst DC, Elliott EG, Michels WM, Gansevoort RT, Halbesma N. Lead and CKD. Nephrol Dial Transplant. 2013;28:e
3 PUBLICATIES NEFROLOGIE 2013 Pagina Guo DH, Parikh SJ, Chao J, Pollock NK, Wang X, Snieder H, Navis GJ, Wilson JG, Bhagatwala J, Zhu H, Dong Y. Urinary prostasin excretion is associated withadiposity in nonhypertensive African-American adolescents. Pediatr Res. 2013;74: Gui J, Moore JH, Williams SM, Andrews P, Hillege HL, Harst P van der, Navis GJ, Gilst WH van, Asselbergs FW, Gilbert-Diamond D. A simple and computationally efficient approach to multifactor dimensionality reduction analysis of gene-gene interactions for quantitative traits. PLoS One. 2013;8:e Haas EC de, Altena R, Boezen HM, Zwart N, Smit AJ, Bakker SJL, Roon AM van, Postma A, Wolffenbuttel BH, Hoekstra HJ, Leeuwen FE van, Sleijfer DT, Gietema JA.Early development of the metabolic syndrome after chemotherapy for testicular cancer. Ann Oncol. 2013;24: Hallan SI, Gansevoort RT. Moderator's view: Estimating glomerular filtration rate--the past, present and future. Nephrol Dial Transplant. 2013;28: Hateren KJ van, Landman GW, Kleefstra N, Groenier KH, Struck J, Navis GJ, Bakker SJL, Houweling ST, Meer K van der, Bilo HJ. The midregional fragment of pro-a-type natriuretic peptide, blood pressure, and mortality in a prospective cohort study of patients with type 2 diabetes (ZODIAC-25). Diabetes Care. 2013;36: Hellemons ME, Lambers Heerspink HJ, Gansevoort RT, Zeeuw D de, Bakker SJL. High-sensitivity troponin T predicts worsening of albuminuria in hypertension; results of a nested case-control study with confirmation in diabetes. J Hypertens. 2013;31: Hoed M den, Eijgelsheim M, Esko T, Brundel BJ, Peal DS, Evans DM, Nolte IM, Segrè AVet al including Navis GJ. Global BPgen Consortium; CARDIoGRAM Consortium; PR GWAS Consortium, Pfeufer A; QRS GWAS Consortium, Sotoodehnia N; QT-IGCConsortium, Newton-Cheh C; CHARGE-AF Consortium, Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet. 2013;45: Holmes MV, Simon T, Exeter HJ, Folkersen L, Asselbergs FW, Guardiola M et al including Gansevoort RT, Navis GJ. Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol. 2013;62: Cooper JA, Palmen J, et al including Gansevoort RT, Navis GJ. Secretory phospholipase A2-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol. 2013;62: Hoogen MW van den, Hesselink DA, Son WJ van, Weimar W, Hilbrands LB. Treatment of steroidresistant acute renal allograft rejection with alemtuzumab. Am J Transplant. 2013;13: Hoogen MW van den, Kho MM, Abrahams AC, Zuilen AD van, Sanders JSF, Dijk MC van, Hilbrands LB, Weimar W, Hoitsma AJ. Effect of a single intraoperative high-dose ATG-fresenius on delayed graft function in donation after cardiac-death donor renal allograft recipients: A randomized study. Exp Clin Transplant. 2013;11: Hu YJ, Berndt SI, Gustafsson S, Ganna A; Genetic Investigation of ANthropometric Traits (GIANT) Consortium, Hirschhorn J, North KE, Ingelsson E, Lin DY including Navis GJ. Meta-analysis of genelevel associations for rare variants based on single-variant statistics. Am J Hum Genet. 2013;93: Jager DJ de, Halbesma N, Krediet RT, Boeschoten EW, le Cessie S, Dekker FW, Grootendorst DC; NECOSAD study group including collaborators Stegeman CA et al. Is the decline of renal function different before and after the start of dialysis? Nephrol Dial Transplant. 2013;28: Joode AAE de, Sanders JSF, Stegeman CA. Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis. Clin J Am Soc Nephrol. 2013;8: Joosten JMH, Eersel ME van, Gansevoort RT, Bilo HJ, Slaets JP, Izaks GJ. Cardiovascular risk profile and cognitive function in young, middle-aged, and elderly subjects. Stroke. 2013;44:
4 PUBLICATIES NEFROLOGIE 2013 Pagina Joosten MM, Gansevoort RT, Mukamal KJ, Kootstra-Ros JE, Feskens EJ, Geleijnse JM, Navis GJ, Bakker SJL; PREVEND Study Group. Urinary magnesium excretion and risk of hypertension: the prevention of renal and vascular end-stage disease study. Hypertension. 2013;61: Joosten MM, Gansevoort RT, Mukamal KJ, Harst P van der, Geleijnse JM, Feskens EJ, Navis GJ, Bakker SJL; PREVEND Study Group. Urinary and plasma magnesium and risk of ischemic heart disease. Am J Clin Nutr. 2013;97: Joosten MM, Gansevoort RT, Mukamal KJ, Kootstra-Ros JE, Feskens EJ, Geleijnse JM, Navis GJ, Bakker SJL; PREVEND Study Group. Response to Lowered magnesium in hypertension. Hypertension. 2013;62:e Kallenberg CGM, Stegeman CA, Abdulahad WH, Heeringa P. Pathogenesis of ANCA-associated vasculitis: New possibilities for intervention. Am J Kidney Dis. 2013;62: Kappelle PJ, Gansevoort RT, Hillege HJ, Wolffenbuttel BHR, Dullaart RPF; PREVEND Study Group. Common variation in Cholesteryl Ester Transfer Protein: Relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/highdensity lipoprotein cholesterol ratio. J Clin Lipidol. 2013;7: Katta K, Boersema M, Adepu S, Rienstra H, Celie JW, Mencke R, Molema G, Goor H van, Berden JH, Navis GJ, Hillebrands JL, van den Born J. Renal heparan sulfate proteoglycans modulate fibroblast growth factor 2 signaling in experimental chronic transplant dysfunction. Am J Pathol. 2013;183: Klein Hesselink EN, Klein Hesselink MS, Bock GH de, Gansevoort RT, Bakker SJL, Vredeveld EJ, Horst-Schrivers AN van der, Horst IC van der, Kamphuisen PW, Plukker JT, Links TP, Lefrandt JD. Longterm cardiovascular mortality in patients with differentiated thyroid carcinoma: an observational study. J Clin Oncol. 2013;10;31: Klooster A, Larkin JR, Wiersema-Buist J, Gans ROB, Thornalley PJ, Navis GJ, Goor H van, Leuvenink HG, Bakker SJL. Are brain and heart tissue prone to the development of thiamine deficiency? Alcohol. 2013;47: Klooster A, Hofker HS, Navis GJ, Homan van der Heide JJ, Gans ROB, Goor H van,leuvenink HG, Bakker SJL. Nonesterified fatty acids and development of graft failure in renal transplant recipients. Transplantation. 2013;95: Köttgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C, Pistis G, Ruggiero D et al including Bakker SJL, Navis GJ; LifeLines Cohort Study; DIAGRAM Consortium; ICBP Consortium; MAGIC Consortium including Navis GJ. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet. 2013;45: Krikken JA, Lely AT, Bakker SJL, Borghuis T, Faas MM, Goor H van, Navis GJ, Bakker WW. Hemopexin activity is associated with angiotensin II responsiveness in humans. J Hypertens. 2013;31: Kuipers J, Usvyat LA, Oosterhuis JK, Dasselaar JJ, Jong PE de, Westerhuis R, Sands JJ, Wang Y, Kotanko P, Franssen CFM. Variability of predialytic, intradialytic, and postdialytic blood pressures in the course of a week: a study of Dutch and US maintenance hemodialysis patients. Am J Kidney Dis. 2013;62: Kwakernaak AJ, Lambert G, Slagman MC, Waanders F, Laverman GD, Petrides F, Dikkeschei BD, Navis GJ, Dullaart RPF. Proprotein convertase subtilisin-kexin type 9 is elevated in proteinuric subjects: Relationship with lipoprotein response to antiproteinuric treatment. Atherosclerosis. 2013;226: Kwakernaak AJ, Zelle DM, Bakker SJL, Navis GJ. Central body fat distribution associates with unfavorable renal hemodynamics independent of body mass index. J Am Soc Nephrol. 2013;24:
5 PUBLICATIES NEFROLOGIE 2013 Pagina Kwakernaak AJ, Toering TJ, Navis GJ. Body mass index and body fat distribution as renal risk factors: a focus on the role of renal haemodynamics. Nephrol Dial Transplant. 2013;Suppl 4:iv Kwakernaak AJ, Waanders F, Slagman MC, Dokter MM, Laverman GD, Boer RA de, Navis GJ. Sodium restriction on top of renin-angiotensin-aldosterone system blockade increases circulating levels of N- acetyl-seryl-aspartyl-lysyl-proline in chronic kidney disease patients. J Hypertens. 2013;31: Lambers Heerspink HJ, Borst MH de, Bakker SJL, Navis GJ. Improving the efficacy of RAAS blockade in patients with chronic kidney disease. Nat Rev Nephrol. 2013;9: Leer-Buter CC van, Sanders JSF, Vroom HE, Riezebos-Brilman A, Niesters HG. Human herpesvirus-6 DNAemia is a sign of impending primary CMV infection in CMV sero-discordant renal transplantations. J Clin Virol. 2013;58: Matsushita K, Ballew SH, Astor BC, Jong PE de, Gansevoort RT, Hemmelgarn BR, Levey AS, Levin A, Wen CP, Woodward M, Coresh J; Chronic Kidney Disease Prognosis Consortium. Cohort profile: the chronic kidney disease prognosis consortium. Int J Epidemiol. 2013;42: Metalidis C, Vuuren SH van, Broekhuizen R, Lerut E, Naesens M, Bakker SJL, Wetzels JF, Goldschmeding R, Kuypers DR. Urinary connective tissue growth factor is associated with human renal allograft fibrogenesis. Transplantation. 2013;96: Meijer E, Drenth JP, d'agnolo H, Casteleijn NF, Fijter JW de, Gevers TJ, Kappert P, Peters DJ, Salih M, Soonawala D, Spithoven EM, Torres VE, Visser FW, Wetzels JF, Zietse R, Gansevoort RT; DIPAK Consortium. Rationale and Design of the DIPAK 1 Study: A Randomized Controlled Clinical Trial Assessing the Efficacy of Lanreotide to Halt Disease Progression in Autosomal Dominant Polycystic Kidney Disease. Am J Kidney Dis. 2013;S (13) Miloslavsky E, Specks U, Merkel P, Seo P, Spiera R, Langford C, Hoffman GS, Kallenberg CGM et al including Stegeman CA; for the RAVE-ITN Research Group. Clinical outcomes of remission induction therapy for severe ANCA-Associated vasculitis. Arthritis Rheum. 2013;65: Mirković K, Doorenbos CR, Dam WA, Lambers Heerspink HJ, Slagman MC, Nauta FL, Kramer AB, Gansevoort RT, Born J van den, Navis GJ, Borst MH de. Urinary vitamin d binding protein: a potential novel marker of renal interstitial inflammation and fibrosis. PLoS One. 2013;8:e Nauta FL, Scheven L, Meijer E, Oeveren W van, Jong PE de, Bakker SJL, Gansevoort RT. Glomerular and Tubular Damage Markers in Individuals with Progressive Albuminuria. Clin J Am Soc Nephrol. 2013;8: Nitsch D, Grams M, Sang Y, Black C, Cirillo M, Djurdjev O, Iseki K, Jassal SK, et al including Chronic Kidney Disease Prognosis Consortium. Collaborators including Gansevoort RT, Jong PE de. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis. BMJ. 2013;346:f Odden MC, Tager IB, Gansevoort RT, Bakker SJL, Fried LF, Newman AB, Katz R, Satterfield S, Harris TB, Sarnak MJ, Siscovick D, Shlipak MG. Hypertension and low HDL cholesterol were associated with reduced kidney function across the age spectrum: a collaborative study. Ann Epidemiol. 2013;23: Özyilmaz A, Bakker SJL, Zeeuw D de, Jong PE de, Gansevoort RT; PREVEND Study Group. Screening for albuminuria with subsequent screening for hypertension and hypercholesterolaemia identifies subjects in whom treatment is warranted to prevent cardiovascular events. Nephrol Dial Transplant. 2013;28: Paul DS, Albers CA, Rendon A, Voss K, Stephens J; HaemGen Consortium, Harst P van der, Chambers JC, Soranzo N, Ouwehand WH, Deloukas P including collaborators Navis GJ et al. Maps of open chromatin highlight cell type-restricted patterns of regulatory sequence variation at hematological trait loci. Genome Res. 2013;23:
6 PUBLICATIES NEFROLOGIE 2013 Pagina Randall JC, Winkler TW, Kutalik Z, Berndt SI, Jackson AU, Monda KL, Kilpeläinen TO, Esko T et al DIAGRAM Consortium, MAGIC Investigators, Hottenga JJ, Prokopenko I, Waite LL, Harris TB, Smith AV, Shuldiner AR et al including Bakker SJL, Navis GJ. Sex-stratified genome-wide association studies Including 270,000 Individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet. 2013;9:e Reznichenko A, Sinkeler SJ, Snieder H, Born J van den, Borst MH de, Damman J, Dijk MC van, Goor H van, Hepkema BG, Hillebrands JL, Leuvenink HG, Niesing J, Bakker SJL, Seelen MAJ, Navis GJ. SLC22A2 is associated with tubular creatinine secretion and bias of estimated GFR in renal transplantation. Physiol Genomics.2013;45: Riezebos-Brilman A, Verschuuren EA, Son WJ van, Imhoff GW van, Brügemann J, Blokzijl H, Niesters HG. The clinical course of hepatitis E virus infection in patients of a tertiary Dutch hospital over a 5-year period. J Clin Virol. 2013;58: Riphagen IJ, Boertien WE, Alkhalaf A, Kleefstra N, Gansevoort RT, Groenier KH, Hateren van KJ, Struck J, Navis GJ, Bilo HJ, Bakker SJL. Copeptin, a surrogate marker for arginine vasopressin, Is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31). Diabetes Care. 2013;36: Roscioni SS, Zeeuw D de, Hellemons ME, Mischak H, Zürbig P, Bakker SJL, Gansevoort RT, Reinhard H, Persson F, Lajer M, Rossing P, Lambers Heerspink HJ. A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus. Diabetologia. 2013;56: Roth AJ, Ooi JD, Hess JJ, Timmeren MM van, Berg EA, Poulton CE, McGregor J, Burkart M et al including Stegeman CA et al. Epitope specificity determines pathogenicity and detectability in ANCAassociated vasculitis. J Clin Invest. 2013;123: Russcher M, Koch BPC, Nagtegaal JE, Ittersum FJ van, Rasker-de Jong PCM, Hagen EC, Dorp WT van, Gabreëls B, Wildbergh TX, Westerlaken MML van der, Gaillard CAJM, Wee PM ter. Long-term effects of melatonin on quality of life and sleep in hemodialysis patients (Melody study): randomized controlled trial. Br J Clin Pharmacol. 2013;76: Scheven L, Halbesma N, Jong PE de, Zeeuw D de, Bakker SJL, Gansevoort RT. Predictors of progression in albuminuria in the general population: results from the PREVEND cohort. PLoS One. 2013;8:e Scheven L, Velde M van der, Lambers Heerspink HJ, Jong PE de, Gansevoort RT. Isolated microalbuminuria indicates a poor medical prognosis. Nephrol Dial Transplant. 2013;28: Schroten NF, Ruifrok WP, Kleijn L, Dokter MM, Silljé HH, Lambers Heerspink HJ, Bakker SJL, Kema IP, Gilst WH van, Veldhuisen DJ van, Hillege HL, Boer RA de. Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial). Am Heart J. 2013;166: Schulz T, Niesing J, Homan van der Heide JJ, Westerhuis R, Ploeg RJ, Ranchor AV. Perceived health after kidney transplantation: a cross-sectional comparison of long-term and short-term cohorts. Transplant Proc. 2013;45: Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT; CKD Prognosis Consortium. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013;369: Shlipak MG, Coresh J, Gansevoort RT. Cystatin C versus creatinine for kidney function-based risk. N Engl J Med. 2013;369: Sim X, Jensen RA, Ikram MK, Cotch MF, Li X, MacGregor S, Xie J, Smith AV et al; Wellcome Trust Case Control Consortium 2, Global BPGen Consortium. Collaborators including Navis GJ, Jong PE de. Genetic loci for retinal arteriolar microcirculation. PLoS One. 2013;8:e65804
7 PUBLICATIES NEFROLOGIE 2013 Pagina Sinkeler SJ, Kwakernaak AJ, Bakker SJL, Shahinfar S, Esmatjes E, Zeeuw D de, Navis GJ, Lambers Heerspink HJ, Heerspink. Creatinine excretion rate and mortality in type 2 diabetes and Nephropathy. Diabetes Care. 2013;36: Snijder PM, Berg E van den, Whiteman M, Bakker SJL, Leuvenink HG, Goor H van. Emerging role of gasotransmitters in renal transplantation. Am J Transplant. 2013;13: Souza AW de, Westra J, Bijzet J, Limburg PC, Stegeman CA, Bijl M, Kallenberg CGM. Is serum HMGB1 a biomarker in ANCA-Associated vasculitis? Arthritis Res Ther.2013;15:R Spithoven EM, Meijer E, Boertien WE, Sinkeler SJ, Tent H, Jong PE de, Navis GJ, Gansevoort RT. Tubular secretion of creatinine in autosomal dominant polycystic Kidney ddisease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations. Am J Kidney Dis. 2013;62: Spithoven EM, Bakker SJl, Kootstra-Ros JE, Jong PE de, Gansevoort RT; DIPAK Consortium Investigators. Stability of creatinine and cystatin C in whole blood. Clin Biochem. 2013;46: Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CGM et al including Stegeman CA; RAVE-ITN Research Group. Efficacy of remission-induction regimens for ANCAassociated vasculitis. N Engl J Med. 2013;369: Spithoven EM, Bakker SJL, Kootstra-Ros JE, Jong PE de, Gansevoort RT; for the DIPAK Consortium Investigators. Stability of creatinine and cystatin C in whole blood. Clin Biochem. 2013;46: Suttorp MM, Hoekstra T, Mittelman M, Ott I, Franssen CFM, Dekker FW. Effect of erythropoiesisstimulating agents on blood pressure in pre-dialysis patients.plos One. 2013;8:e Teunissen-Beekman KF, Dopheide J, Geleijnse JM, Bakker SJL, Brink EJ, Leeuw PW de, Serroyen J, Baak MA van. Blood pressure decreases more after high-carbohydrate meals than after high-protein meals in overweight adults with elevated blood pressure, but there is no difference after 4 weeks of consuming a carbohydrate-rich or protein-rich diet. J Nutr. 2013;143: Tielemans SM, Altorf-van der Kuil W, Engberink MF, Brink EJ, Baak MA van, Bakker SJL, Geleijnse JM. Intake of total protein, plant protein and animal protein in relation to blood pressure: a meta-analysis of observational and intervention studies. J Hum Hypertens. 2013;27: Tielemans SM, Geleijnse JM, Baak MA van, Engberink MF, Brink EJ, Jong PE de, Gansevoort RT, Bakker SJL; PREVEND Study Group. Twenty-four hour urinary urea excretion and 9-year risk of hypertension: the PREVEND study. J Hypertens. 2013;31: Toering TJ, Navis GJ, Lely AT. The role of the VEGF-C signaling pathway in preeclampsia? J Reprod Immunol. 2013;100: Torres VE, Gansevoort RT, Czerwiec FS. Tolvaptan in autosomal dominant polycystic kidney disease. N Engl J Med. 2013;368: Tuin J, Sanders JSF, Buhl BM, Beek AP van, Stegeman CA. Androgen deficiency in male patients diagnosed with ANCA-associated vasculitis: a cause of fatigue and reduced health-related quality of life? Arthritis Res Ther. 2013;15:R Turin TC, Coresh J, Tonelli M, Stevens PE, Jong PE de, Farmer CK, Matsushita K, Hemmelgarn BR. Change in the estimated glomerular filtration rate over time and risk of all-cause mortality. Kidney Int. 2013;83: Vader P, Fens MH, Sachini N, Oirschot BA van, Andringa G, Egberts AC, Gaillard CAJM, Rasmussen JT, Wijk R van, Solinge WW van, Schiffelers RM. Taxol( )-induced phosphatidylserine exposure and microvesicle formation in red blood cells is mediated by its vehicle Cremophor( ) EL. Nanomedicine (Lond). 2013;8: Vart P, Gansevoort RT, Coresh J, Reijneveld SA, Bültmann U. Socioeconomic measures and CKD in the United States and The Netherlands. Clin J Am Soc Nephrol. 2013;8:
8 PUBLICATIES NEFROLOGIE 2013 Pagina Verweij N, Mahmud H, Mateo Leach I, Boer RA de, Brouwers FP, Yu H, Asselbergs FW, Struck J, Bakker SJL, Gansevoort RT, Munroe PB, Hillege HL, Veldhuisen DJ van, Gilst WH van, Silljé HH, Harst P van der. Genome-wide association study on plasmalevels of midregional-proadrenomedullin and C- terminal-pro-endothelin-1. Hypertension. 2013;61: Werkhoven MB van, Damman J, Daha MR, Krikke C, Goor H van, Son WJ van, Hillebrands JL, Dijk MC van, Seelen MAJ. Novel insights in localization and expression levels of C5aR and C5L2 under native and post-transplant conditions in the kidney. Mol Immunol. 2013;53: Werkhoven MB van, Damman J, Dijk MC van, Daha MR, Jong IJ de, Leliveld A, Krikke C, Leuvenink HG, Goor H van, Son WJ van, Olinga P, Hillebrands JL, Seelen MAJ. Complement mediated renal inflammation induced by donor brain death: Role of renal C5a-C5aR interaction. Am J Transplant. 2013;13: Zelle DM, Corpeleijn E, Deinum J, Stolk RP, Gans ROB, Navis GJ, Bakker SJL. Pancreatic β-cell dysfunction and risk of new-onset diabetes after kidney transplantation. Diabetes Care. 2013;36: Zelle DM, Kok T, Dontje ML, Danchell EI, Navis GJ, Son WJ van, Bakker SJL, Corpeleijn E. The role of diet and physical activity in post-transplant weight gain after renal transplantation. Clin Transplant. 2013;27:E DISSERSATIES Berg van den E Nutrition and cardiovascular health in renal transplant recipients Promtores: prof dr GJ Navis, prof dr ROB Gans Copromotor: dr SJL Bakker Groningen, Alkhalaf A Novel approaches in diabetic Nephropathy Promotores: prof dr GJ Navis, prof dr HJG Bilo Copromotoren: dr SJL Bakker, dr N Kleefstra Groningen, Abbasi A Biomarkers and prediction models for type 2 diabetes and diabetes related outcomes Promotores: prof dr RP Stolk and prof dr GJ Navis Copromotores: dr SJL. Bakker, dr. ir. E. Corpeleijn and r. ir. JW. Beulens Groningen Smink PA Biomarkers and assessment of drug efficacy in cardiovascular disease Promotor: prof dr D de Zeeuw Copromotores: dr HJ Lambers Heerspink, dr SJL Bakker
9 PUBLICATIES NEFROLOGIE 2013 Pagina Groningen Velde van der M Renal risk markers and patient prognosis in chronic kidney disease Promotor: prof dr PE de Jong Copromotor: dr RT Gansevoort Groningen Klooster A Thiamine, fasting and the kidney Promotor: prof dr H van Goor Copromotores: dr SJL Bakker, dr HGD Leuvelink Groningen Zelle DM Lifestyle, the next target for intervention in renal transplant recipients Promotores: prof dr GJ Navis, prof dr RP Stolk Copromotores: dr SJL Bakker, dr ir E Corpeleijn Groningen HOOFDSTUK BOEK
PUBLICATIES NEFROLOGIE 2012
PUBLICATIES NEFROLOGIE 2012 1. Abbasi A, Corpeleijn E, Peelen LM, Gansevoort RT, Jong PE de, Gans ROB, Rathmann W, Kowall B, Meisinger C, Hillege HL, Stolk RP, Navis GJ, Beulens JW, Bakker SJL. External
More informationVictims Compensation Claim Status of All Pending Claims and Claims Decided Within the Last Three Years
Claim#:021914-174 Initials: J.T. Last4SSN: 6996 DOB: 5/3/1970 Crime Date: 4/30/2013 Status: Claim is currently under review. Decision expected within 7 days Claim#:041715-334 Initials: M.S. Last4SSN: 2957
More informationPublicaties Nefrologie 2014 Pagina 1 31-3-2015
Publicaties Nefrologie 2014 Pagina 1 31-3-2015 1. Abbasi A, Stolk RP, Bakker SJL. Identification of relevant biomarkers for type 2 diabetes. Lancet Diabetes Endocrinol. 2014;2:106-7 2. Abbasi A, Corpeleijn
More informationNierfunctiemeting en follow-up van chronisch nierlijden
Nierfunctiemeting en follow-up van chronisch nierlijden 12 Jan 2016 Patrick Peeters, M.D. Dept Nephrology Ghent University Hospital Plan of presentation 1/ Renal function determination: Measured GFR Estimated
More informationHow To Know If Low Protein Diet Is Beneficial For Kidney Health
Protein Intake and Diabetic Kidney Disease Robert C. Stanton Joslin Diabetes Center 1/Serum Creatinine Plot Low Protein Protects in Renal Ablation Model 24% Protein Diet 6% Protein Diet Right Nephrectomy
More informationDose-Response Effects of Sodium Intake on Blood Pressure
I Dose-Response Effects of Sodium Intake on 1 +2 NS +1 NS -2 NS +5 NS 0.46 (20) 4.6 () 25.9 (1128) FIGURE I-1 Blood pressure (mm Hg) according to dietary sodium intake in g/d (mmol/d) among 8 normotensive
More informationPrevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한
Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한 Introduction CKD의 정의와 egfr의 측정 CKD의 risk factor와 mechanism 한국의 CKD prevalence 와 prognosis CKD의 치료와
More informationUsing multiple biomarkers to predict renal and cardiovascular drug efficacy: Implications for drug development and registration
Using multiple biomarkers to predict renal and cardiovascular drug efficacy: Implications for drug development and registration Hiddo Lambers Heerspink Department of Clinical Pharmacology University Medical
More informationDiabetic Nephropathy
Diabetic Nephropathy Kidney disease is common in people affected by diabetes mellitus Definition Urinary albumin excretion of more than 300mg in a 24 hour collection or macroalbuminuria Abnormal renal
More informationMetabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007
Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering
More informationRATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra
RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent
More informationElective Project Report
Elective Project Report I spent my elective at The Royal Free Hospital, London doing renal medicine. I decided to undertake my elective in renal medicine for two reasons: 1) I am very interested in this
More informationKIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA
KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA O.E. Stakhvoskyi, E.O. Stakhovsky, Y.V. Vitruk, O.A. Voylenko, P.S. Vukalovich, V.A. Kotov, O.M. Gavriluk National Canсer Institute,
More informationSystolic Blood Pressure Intervention Trial (SPRINT) Principal Results
Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and
More informationThe sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C:
The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C: The good correlation allows close estimation of GFR Cystatin C GFR GFR in serum estimated* measured* n
More informationVitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr
Vitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr Stefan Pilz Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, Austria Department
More informationMicroalbuminuria: An increasingly recognized risk factor for CVD
Microalbuminuria: An increasingly recognized risk factor for CVD Long known to be associated with kidney disease, the importance of protein in the urine is now becoming recognized as a sensitive, accessible
More informationPROCEEDINGS DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT
DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT Diabetic nephropathy affects people with either type 1 or type 2 diabetes mellitus.
More informationDefinition, Prevalence, Pathophysiology and Complications of CKD. JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013
Definition, Prevalence, Pathophysiology and Complications of CKD JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013 KI supplements January 2013 Objectives of the course on CKD:
More informationKDIGO THE GEORGE INSTITUTE FOR GLOBAL HEALTH. Antiocoagulation in diabetes and CKD Vlado Perkovic
THE GEORGE INSTITUTE FOR GLOBAL HEALTH Antiocoagulation in diabetes and CKD Vlado Perkovic Executive Director, George Institute Australia Professor of Medicine, University of Sydney Affiliated with the
More informationAlbuminuria as a Marker of the Risk of Developing Type 2 Diabetes in Non- Diabetic Aboriginal Australians
Albuminuria as a Marker of the Risk of Developing Type 2 Diabetes in Non- Diabetic Aboriginal Australians Zhiqiang Wang 1 and Wendy E Hoy 1 Centre for Chronic Disease, Department of Medicine, Central Clinical
More informationUpdate in Contrast Induced Nephropathy
Update in Contrast Induced Nephropathy Yves Pirson Service de Néphrologie, Clin. Univ. St-Luc - UCL A 76-year-old man with - type 2 diabetes - CKD (ser. creat.: 1.8 mg/dl; GFR: 32) presents with angina
More informationProtocol: Testosterone and cardiovasclar related events in men: a meta analysis of randomized controlled trials. Version: 1. Date: 5 th December 2011
Protocol: Testosterone and cardiovasclar related events in men: a meta analysis of randomized controlled trials Version: 1 Date: 5 th December 2011 Study team: C Mary Schooling, CUNY School of Public Health
More informationHow To Know If You Have Microalbuminuria
3 PREVALENCE AND PREDICTORS OF MICROALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL OBSERVATIONAL STUDY Dr Ashok S Goswami *, Dr Janardan V Bhatt**; Dr Hitesh Patel *** *Associate
More informationPrediction of Kidney Disease Progression in Patients with Diabetes
Prediction of Kidney Disease Progression in Patients with Diabetes John Arthur, MD, PhD Medical University of South Carolina SEKDC Meeting September 8, 2012 Objectives Understand the importance of predicting
More informationIn many diabetes units, people with type
Renal Microalbuminuria: Screening and management in type 2 diabetes Julia Arundale Introduction In many diabetes units, patients with type 1 or type 2 diabetes are screened for proteinuria. Screening for
More informationEstimated GFR Based on Creatinine and Cystatin C
Estimated GFR Based on Creatinine and Cystatin C Lesley A Stevens, MD, MS Tufts Medical Center, Tufts University School of Medicine Boston MA Chronic Kidney Disease-Epidemiology Collaboration UO1 DK 053869,
More informationSmall artery tone under control of the endothelium
Small artery tone under control of the endothelium On the importance of EDHF and myogenic tone in organ (dys)function Simone K. Gschwend Publication of this thesis was supported by generous contributions
More information25-hydroxyvitamin D: from bone and mineral to general health marker
DIABETES 25 OH Vitamin D TOTAL Assay 25-hydroxyvitamin D: from bone and mineral to general health marker FOR OUTSIDE THE US AND CANADA ONLY Vitamin D Receptors Brain Heart Breast Colon Pancreas Prostate
More informationAppendix: Description of the DIETRON model
Appendix: Description of the DIETRON model Much of the description of the DIETRON model that appears in this appendix is taken from an earlier publication outlining the development of the model (Scarborough
More information嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯
The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Adults with Type 2 Diabetes Mellitus 嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 Diabetes Mellitus : A group of diseases characterized
More informationGUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY*
71 GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY* Ryuichi KIKKAWA** Asian Med. J. 44(2): 71 75, 2001 Abstract: Diabetic nephropathy is the most devastating complication of diabetes and is now the
More informationPackage nephro. February 23, 2015
Type Pack Title Biostatistics Utilities for Nephrology Version 1.1 Date 2015-01-31 Author Pack nephro February 23, 2015 Maintainer Set of functions to estimate the Glomerular
More informationGuideline for Microalbuminuria Screening
East Lancashire Diabetes Network Guideline for Microalbuminuria Screening Produced by: Task and Finish Group, Clinical Standards Group Produced: August 2006 Approved by: East Lancashire Diabetes Network
More informationAbsolute cardiovascular disease risk assessment
Quick reference guide for health professionals Absolute cardiovascular disease risk assessment This quick reference guide is a summary of the key steps involved in assessing absolute cardiovascular risk
More informationHow To Know If You Have Microalbuminuria
HIPPOKRATIA 2013, 17, 4: 337-341 ORIGINAL ARTICLE Prevalence of microalbuminuria and risk factor analysis in type 2 diabetes patients in Albania: the need for accurate and early diagnosis of diabetic nephropathy
More informationDietary treatment of cachexia challenges of nutritional research in cancer patients
Dietary treatment of cachexia challenges of nutritional research in cancer patients Trude R. Balstad 4th International Seminar of the PRC and EAPC RN, Amsterdam 2014 Outline Cancer cachexia Dietary treatment
More informationEffect of Elevated Creatinine Level in Blood Serum of Chronic Renal Failure Patients
Biological Forum An International Journal 6(1): 48-52(2014) ISSN No. (Print): 0975-1130 ISSN No. (Online): 2249-3239 Effect of Elevated Creatinine Level in Blood Serum of Chronic Renal Failure Patients
More informationUse of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus
Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Number 84 Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus Summary Overview Clinical
More informationESCMID Online Lecture Library. by author
Do statins improve outcomes of patients with sepsis and pneumonia? Jordi Carratalà Department of Infectious Diseases Statins for sepsis & community-acquired pneumonia Sepsis and CAP are major healthcare
More informationAlbuminuria versus GFR as markers of diabetic CKD progression
Albuminuria versus GFR as markers of diabetic CKD progression KDIGO Controversies Conference: Diabetic Kidney Disease New Delhi, March 2012 Richard J MacIsaac PhD FRACP Director of Endocrinology & Diabetes,
More informationJill Malcolm, Karen Moir
Evaluation of Fife- DICE: Type 2 diabetes insulin conversion Article points 1. Fife-DICE is an insulin conversion group education programme. 2. People with greater than 7.5% on maximum oral therapy are
More informationImproving cardiometabolic health in Major Mental Illness
Improving cardiometabolic health in Major Mental Illness Dr. Adrian Heald Consultant in Endocrinology and Diabetes Leighton Hospital, Crewe and Macclesfield Research Fellow, Manchester University Metabolic
More informationYour healthcare provider has ordered a Boston Heart Cardiac Risk Assessment
Your healthcare provider has ordered a Boston Heart Cardiac Risk Assessment What does that mean for you? Your healthcare provider has determined that you may be at risk for cardiovascular disease (CVD).
More informationWorld Kidney Day 11 March 2010: we must act on diabetic kidney disease
November 11, 2009 Diabetic kidney disease: Act now or pay later Robert C Atkins and Paul Zimmet For the 2010 International Society of Nephrology/International Federation of Kidney Foundations World Kidney
More informationPrimary Care Guidance Program: Non-Alcohol related Fatty Liver Disease (NAFLD) Guidance on Management in Primary Care
Primary Care Guidance Program: Non-Alcohol related Fatty Liver Disease (NAFLD) Guidance on Management in Primary Care This advice has been developed to help GPs with shared care of patients with Non- Alcohol
More informationUCSF Kidney Transplant Symposium 2012
UCSF Kidney Transplant Symposium 2012 Nutrition Fitness in Kidney Transplant Mary Ellen DiPaola, RD, CDE UCSF Outpatient Dietitian Goal of Nutrition Fitness for Transplant Nutritional guidance of pre-
More informationAlbumin and All-Cause Mortality Risk in Insurance Applicants
Copyright E 2010 Journal of Insurance Medicine J Insur Med 2010;42:11 17 MORTALITY Albumin and All-Cause Mortality Risk in Insurance Applicants Michael Fulks, MD; Robert L. Stout, PhD; Vera F. Dolan, MSPH
More informationUrine Protein/Creatinine Ratio as a Mortality Risk Predictor in Non-Diabetics with Normal Renal Function
JOURNAL OF INSURANCE MEDICINE Copyright E 2012 Journal of Insurance Medicine J Insur Med 2012;43:76 83 MORTALITY Urine Protein/Creatinine Ratio as a Mortality Risk Predictor in Non-Diabetics with Normal
More informationOverview of Diabetes Management. By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health
Overview of Diabetes Management By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health Objectives: Describe the pathophysiology of diabetes. From a multiorgan systems viewpoint. Identify the types of diabetes.
More informationDATING YOUR GUILD 1952-1960
DATING YOUR GUILD 1952-1960 YEAR APPROXIMATE LAST SERIAL NUMBER PRODUCED 1953 1000-1500 1954 1500-2200 1955 2200-3000 1956 3000-4000 1957 4000-5700 1958 5700-8300 1959 12035 1960-1969 This chart displays
More informationDiabetes and the Kidneys
Diabetes and the Kidneys Aim(s) and objective(s) This guideline focuses on the detection, prevention, and management of kidney disease in people with diabetes. The management of end-stage renal disease
More informationDISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD
STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with
More informationThe WHI 12 Years Later: What Have We Learned about Postmenopausal HRT?
AACE 23 rd Annual Scientific and Clinical Congress (2014) Syllabus Materials: The WHI 12 Years Later: What Have We Learned about Postmenopausal HRT? JoAnn E. Manson, MD, DrPH, FACP, FACE Chief, Division
More informationDCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study
DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study National Diabetes Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What
More informationDrug Treatment in Type 2 Diabetes with Hypertension
Hypertension is 1.5 2 times more prevalent in Type 2 diabetes (prevalence up to 80 % in diabetic subjects). This exacerbates the risk of cardiovascular disease by ~ two-fold. Drug therapy reduces the risk
More informationRenal Disease in Type 2 Diabetes Mellitus
Renal Disease in Type 2 Diabetes Mellitus 6th Collaborative DiGP/HSE/UCC Conference 25 th September 2013 Dr. Eoin O Sullivan Consultant Endocrinologist Bon Secours Hospital Cork Case 69 year old woman
More informationPrescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital
Research Article Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital *T. JANAGAN 1, R. KAVITHA 1, S. A. SRIDEVI
More informationsurvival, morality, & causes of death Chapter Nine introduction 152 mortality in high- & low-risk patients 154 predictors of mortality 156
introduction 152 < mortality in high- & low-risk patients 154 < predictors of mortality 156 < impact of anemia & dialysis therapy on mortality 158 < mortality in esrd patients with rare s 16 < expected
More informationGFR (Glomerular Filtration Rate) A Key to Understanding How Well Your Kidneys Are Working
GFR (Glomerular Filtration Rate) A Key to Understanding How Well Your Kidneys Are Working www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National
More informationDo albuminuria and hs-crp add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome?
NDT Advance Access published January 9, 2012 Nephrol Dial Transplant (2012) 0: 1 9 doi: 10.1093/ndt/gfr634 Original Article Do albuminuria and hs-crp add to the International Diabetes Federation definition
More informationGuide to Biostatistics
MedPage Tools Guide to Biostatistics Study Designs Here is a compilation of important epidemiologic and common biostatistical terms used in medical research. You can use it as a reference guide when reading
More informationTake a moment Confer with your neighbour And try to solve the following word picture puzzle slides.
Take a moment Confer with your neighbour And try to solve the following word picture puzzle slides. Example: = Head Over Heels Take a moment Confer with your neighbour And try to solve the following word
More informationProtocol. Cardiac Rehabilitation in the Outpatient Setting
Protocol Cardiac Rehabilitation in the Outpatient Setting (80308) Medical Benefit Effective Date: 07/01/14 Next Review Date: 09/15 Preauthorization No Review Dates: 07/07, 07/08, 05/09, 05/10, 05/11, 05/12,
More informationHypertension and Diabetes
Hypertension and Diabetes C.W. Spellman, D.O., Ph.D., FACOI Professor & Associate Dean Research Dir. Center Diabetes & Metabolic Disorders Texas Tech University Health Science Center Midland-Odessa, Texas
More informationA list of FDA-approved testosterone products can be found by searching for testosterone at http://www.accessdata.fda.gov/scripts/cder/drugsatfda/.
FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke
More informationDietary Composition for Weight Loss and Weight Loss Maintenance
Dietary Composition for Weight Loss and Weight Loss Maintenance Bridget M. Hron, MD Instructor in Pediatrics, Harvard Medical School Staff Physician in Gastroenterology & Nutrition and New Balance Foundation
More informationCan Common Blood Pressure Medications Cause Diabetes?
Can Common Blood Pressure Medications Cause Diabetes? By Nieske Zabriskie, ND High blood pressure, or hypertension, is a major risk factor for cardiovascular disease. In the United States, approximately
More informationDiabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus
Melissa Meredith M.D. Diabetes mellitus is a group of metabolic diseases characterized by high blood glucose resulting from defects in insulin secretion, insulin action, or both Diabetes is a chronic,
More information1.- L a m e j o r o p c ió n e s c l o na r e l d i s co ( s e e x p li c a r á d es p u é s ).
PROCEDIMIENTO DE RECUPERACION Y COPIAS DE SEGURIDAD DEL CORTAFUEGOS LINUX P ar a p od e r re c u p e ra r nu e s t r o c o rt a f u e go s an t e un d es a s t r e ( r ot u r a d e l di s c o o d e l a
More informationGuidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes
Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes U.S. Department of Health and Human Services Food and Drug Administration Center
More informationDiagnosis, classification and prevention of diabetes
Diagnosis, classification and prevention of diabetes Section 1 1 of 4 Curriculum Module II 1 Diagnosis, classification and presentation of diabetes Slide 2 of 48 Polyurea Definition of diabetes Slide 3
More informationYour Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007
Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007 The cardiometabolic risk syndrome is increasingly recognized
More informationΗ δίαιτα στην πρόληψη του αγγειακού εγκεφαλικού επεισοδίου
ΠΡΟΓΡΑΜΜΑ ΜΕΤΑΠΤΥΧΙΑΚΩΝ ΣΠΟΥΔΩΝ «Η ΔΙΑΤΡΟΦΗ ΣΤΗΝ ΥΓΕΙΑ ΚΑΙ ΣΤΗ ΝΟΣΟ» Η δίαιτα στην πρόληψη του αγγειακού εγκεφαλικού επεισοδίου Γεώργιος Ντάιος Παθολογική Κλινική Πανεπιστημίου Θεσσαλίας Stroke Statistics
More informationHow To Determine The Prevalence Of Microalbuminuria
Research Journal of Pharmaceutical, Biological and Chemical Sciences Prevalence of Microalbuminuria in relation to HbA1c among known Type2 Diabetic Patients in Puducherry population Muraliswaran P 1 *,
More informationUnderstanding diabetes Do the recent trials help?
Understanding diabetes Do the recent trials help? Dr Geoffrey Robb Consultant Physician and Diabetologist CMO RGA UK Services and Partnership Assurance AMUS 25 th March 2010 The security of experience.
More informationMicroalbuminuria: We are in the midst of an epidemic: the epidemic. So What s a Little Protein? Malcolm s diabetes. How much is too much?
Focus on CME at the University of Saskatchewan Microalbuminuria: So What s a Little Protein? By Judith T. Klassen, BSc, MD, FRCPC University of Saskatchewan Practical Management of Common Medical Problems
More informationDiabetes, hypertension and a lot more `in the elderly` JORIS SCHAKEL INTERNIST- CLINICAL GERIATRICIAN JGSCHAKEL@SEHOS.CW
Diabetes, hypertension and a lot more `in the elderly` JORIS SCHAKEL INTERNIST- CLINICAL GERIATRICIAN JGSCHAKEL@SEHOS.CW IT`S HARD TO GIVE GENERAL ADVICE! ``The Elderly`` Heterogeneous group ;widely varying
More informationDiabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.
Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years
More informationChronic Kidney Disease and Diabetes
Anyone with diabetes can get kidney disease. Diabetes and high blood pressure are the most common causes of kidney disease, and people often have both. Chronic (long term) kidney disease (CKD) caused by
More informationTeam members: E.A.M. Verschuuren (captain), e.a.m.verschuuren@umcg.nl B. van der Blink, b.vanderblink@erasmusmc.nl H.G. Otten, h.g.otten@umcutrecht.
NRS Roadmap Lung Transplantation Team members: E.A.M. Verschuuren (captain), e.a.m.verschuuren@umcg.nl B. van der Blink, b.vanderblink@erasmusmc.nl H.G. Otten, h.g.otten@umcutrecht.nl 1. Inventory of Dutch
More information( Diabetic nephropathy) ( Microalbuminuria ) ( Macroalbuminuria )
2006 17 99-105 2006 20-40% ( ESRD ) 30 299 mg ( ) ( 300 mgday ) DCCBs ) dihydropyridine calcium channel blockers ( non- DCCBs ( -blockers ( diuretics ) 10%) 0.8 ( 60 mlmin per 1.73 m 2 30 mlmin per 1.73
More informationPsychosocial and medical determinants of long-term patient outcomes
Psychosocial and medical determinants of long-term patient outcomes A specific focus on patients after kidney transplantation and with haemophilia Lucia Prihodova Copyright 2014 Lucia Prihodova Copyright
More informationInDependent Diabetes Trust
InDependent Diabetes Trust Kidneys and Diabetes Updated July 2015 Registered Company Number 3148360 Registered Charity No 1058284 Contents Introduction Healthy Kidneys Kidney disease and diabetes The use
More informationTreatment of diabetes In order to survive, people with type 1 diabetes must have insulin delivered by a pump or injections.
National Diabetes Statistics What is diabetes? Diabetes mellitus is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin production, insulin action, or both.
More informationFastTest. You ve read the book... ... now test yourself
FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. Please refer back to relevant sections
More informationIsagenix Clinical Research Summary Suk Cho, Ph.D., Eric Gumpricht, Ph.D., David Despain, M.Sc.
Isagenix Clinical Research Summary Suk Cho, Ph.D., Eric Gumpricht, Ph.D., David Despain, M.Sc. UIC study finds subjects on Isagenix products lost more body fat, lost more visceral fat, showed greater adherence,
More informationAnticoagulants in Atrial Fibrillation
Anticoagulants in Atrial Fibrillation Starting and Stopping Them Safely Carmine D Amico, D.O. Overview Learning objectives Introduction Basic concepts Treatment strategy & options Summary 1 Learning objectives
More informationHYPERTENSION ASSOCIATED WITH RENAL DISEASES
RENAL DISEASE v Patients with renal insufficiency should be encouraged to reduce dietary salt and protein intake. v Target blood pressure is less than 135-130/85 mmhg. If patients have urinary protein
More informationPrimary prevention of chronic kidney disease: managing diabetes mellitus to reduce the risk of progression to CKD
Primary prevention of chronic kidney disease: managing diabetes mellitus to reduce the risk of progression to CKD Date written: July 2012 Author: Kate Wiggins, Graeme Turner, David Johnson GUIDELINES We
More informationStatistics of Type 2 Diabetes
Statistics of Type 2 Diabetes Of the 17 million Americans with diabetes, 90 percent to 95 percent have type 2 diabetes. Of these, half are unaware they have the disease. People with type 2 diabetes often
More informationNP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum
OVERVIEW OF THE FELLOWSHIP The goal of the AASLD NP/PA Fellowship is to provide a 1-year postgraduate hepatology training program for nurse practitioners and physician assistants in a clinical outpatient
More informationDiabetes and Your Kidneys
American Kidney Fund reaching out giving hope improving lives Diabetes and Your Kidneys reaching out giving hope improving lives Diabetes: The #1 Cause of Kidney Failure Your doctor told you that you have
More informationHealthy Aging Lab: Current Research Abstracts
Healthy Aging Lab: Current Research Abstracts Arsenic Exposure and Women s Health Environmental exposure to inorganic arsenic is an indisputable source of increased risk of several human cancers and chronic
More informationThe Blood Cancer Twice As Likely To Affect African Americans: Multiple Myeloma
The Blood Cancer Twice As Likely To Affect African Americans: Multiple Myeloma 11 th Annual National Leadership Summit on Health Disparities Innovation Towards Reducing Disparities Congressional Black
More informationCardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease
Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease What is Cardiac Rehabilitation? Cardiac rehabilitation is a comprehensive exercise, education, and behavior modification
More informationHigh Blood Pressure and Kidney Disease
High Blood Pressure and Kidney Disease National Kidney and Urologic Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH The kidneys play a key
More informationAbsolute cardiovascular disease risk management
Quick reference guide for health professionals Absolute cardiovascular disease risk management This quick reference guide is for use by health professionals for primary prevention of cardiovascular disease
More informationCME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus
CME Test for AMDA Clinical Practice Guideline Diabetes Mellitus Part I: 1. Which one of the following statements about type 2 diabetes is not accurate? a. Diabetics are at increased risk of experiencing
More informationThe Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery
The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery Michael E. Farkouh, MD, MSc Peter Munk Chair in Multinational Clinical Trials Director, Heart and Stroke
More information